Regulatory T cells recruited through CCL22/CCR4 are selectively activated in lymphoid infiltrates surrounding primary breast tumors and lead to an adverse clinical …

…, A Puisieux, C Caux, JY Blay, C Ménétrier-Caux - Cancer research, 2009 - AACR
Immunohistochemical analysis of FOXP3 in primary breast tumors showed that a high number
of tumor-infiltrating regulatory T cells (Ti-Treg) within lymphoid infiltrates surrounding the …

[HTML][HTML] Targeting adenosine in cancer immunotherapy to enhance T-cell function

…, D Alatzoglou, M Irving, C Ménétrier-Caux… - Frontiers in …, 2019 - frontiersin.org
T cells play a critical role in cancer control, but a range of potent immunosuppressive
mechanisms can be upregulated in the tumor microenvironment (TME) to abrogate their activity. …

Impaired IFN-α production by plasmacytoid dendritic cells favors regulatory T-cell expansion that may contribute to breast cancer progression

…, A Puisieux, I Puisieux, JY Blay, C Ménétrier-Caux… - Cancer research, 2012 - AACR
Infiltration and dysfunction of immune cells have been documented in many types of cancers.
We previously reported that plasmacytoid dendritic cells (pDC) within primary breast …

Quantitative and functional alterations of plasmacytoid dendritic cells contribute to immune tolerance in ovarian cancer

…, A Cassignol, O Tredan, I Durand, C Ménétrier-Caux… - Cancer research, 2011 - AACR
In ovarian cancer, the immune system fails to eradicate established tumors partly due to the
induction of immune tolerance within tumor microenvironment. In this study, we investigated …

ICOS-Ligand Expression on Plasmacytoid Dendritic Cells Supports Breast Cancer Progression by Promoting the Accumulation of Immunosuppressive CD4+ T Cells

…, S Chabaud, JY Blay, C Caux, C Ménétrier-Caux - Cancer research, 2012 - AACR
Human breast tumors are infiltrated by memory CD4 + T cells along with increased numbers
of regulatory T cells (Treg) and plasmacytoid dendritic cells (pDC) that facilitate immune …

[HTML][HTML] Lymphopenia in cancer patients and its effects on response to immunotherapy: an opportunity for combination with cytokines?

C Ménétrier-Caux, I Ray-Coquard, JY Blay… - … for immunotherapy of …, 2019 - Springer
Quantitative lymphocyte alterations are frequent in patients with cancer, and strongly impact
prognosis and survival. The development of cancers in immunosuppressed patients has …

[HTML][HTML] Adenosine mediates functional and metabolic suppression of peripheral and tumor-infiltrating CD8+ T cells

…, G Coukos, C Jandus, C Ménétrier-Caux… - … for immunotherapy of …, 2019 - Springer
Background Several mechanisms are present in the tumor microenvironment (TME) to
impair cytotoxic T cell responses potentially able to control tumor growth. Among these, the …

Interleukin-6, interleukin-10, and vascular endothelial growth factor in metastatic renal cell carcinoma: prognostic value of interleukin-6—from the Groupe Francais d' …

S Negrier, D Perol, C Menetrier-Caux… - Journal of clinical …, 2004 - ascopubs.org
Purpose Few clinical prognostic factors have been identified for patients with metastatic renal
cell carcinoma (MRCC), and no biomarker is known in this disease. Several endogenous …

Early Detection of Tumor Cells by Innate Immune Cells Leads to Treg Recruitment through CCL22 Production by Tumor Cells

…, S Léon-Goddard, JY Blay, C Caux, C Ménétrier-Caux - Cancer research, 2011 - AACR
In breast carcinomas, patient survival seems to be negatively affected by the recruitment of
regulatory T cells (T reg ) within lymphoid aggregates by CCL22. However, the mechanisms …

Differences in tumor regulatory T-cell localization and activation status impact patient outcome

C Ménétrier-Caux, M Gobert, C Caux - Cancer Research, 2009 - AACR
The presence of regulatory T cells (Treg) has been described in a large panel of solid tumors.
However, their impact on tumor progression differs according to the tumor type analyzed. …